Memantine and anorexia Patient Reports February 12, 2012

Memantine Side Effects Report #4551190-1
Memantine side effect was reported by a Health Professional from on Dec 21, 2004. Female patient, 83 years of age, weighting 154.3 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: aggression, anorexia, anxiety , atherosclerosis, bladder pain, blood pressure immeasurable, cardiac failure, cerebral atrophy, cold sweat. Memantine dosage: 20 MG QD PO. During the same period patient was treated with BEHEPAN, FOLACIN, KATAIPOS D, OXASCAN, HEMINEURIN, ZOPLIKON. Patient died on 11/14/2004.

Memantine Side Effects Report #5246154-9
Memantine side effect was reported by a Health Professional from JAPAN on Feb 08, 2007. Male patient, 80 years of age, weighting 87.96 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: anorexia, aspartate aminotransferase increased, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, c-reactive protein increased, depressed level of consciousness. Memantine dosage: unknown. During the same period patient was treated with CERNITIN POLLEN, TAMSULOSIN, MAGNESIUM OXIDE, EPINASTINE HYDROCHLORIDE, CROTAMITON. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5306746-5
Memantine side effect was reported by a Health Professional from JAPAN on Apr 09, 2007. Male patient, 80 years of age, weighting 87.96 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: anorexia, aspartate aminotransferase increased, blood lactate dehydrogenase increased, decubitus ulcer, depressed level of consciousness, white blood cell count increased. Memantine dosage: unknown. During the same period patient was treated with CERNITIN POLLEN, TAMSULOSIN, MAGNESIUM OXIDE, EPINASTINE HYDROCHLORIDE, CROTAMITON. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5310147-3
Memantine side effect was reported by a Health Professional from JAPAN on Apr 12, 2007. Male patient, 80 years of age, weighting 87.96 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, blood lactate dehydrogenase increased, blood pressure decreased, blood pressure systolic decreased, decubitus ulcer, depressed level of consciousness, productive cough. Memantine dosage: unknown. During the same period patient was treated with CERNITIN POLLEN, TAMSULOSIN, MAGNESIUM OXIDE, EPINASTINE HYDROCHLORIDE, CROTAMITON. Patient was hospitalized. Patient recovered.


Memantine Side Effects Report #5209118-7
Memantine side effect was reported by a Health Professional from JAPAN on Dec 29, 2006. Male patient, 78 years of age, weighting 114.6 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: anorexia, dehydration, jaundice cholestatic, malnutrition, metastases to liver, metastases to lymph nodes, pancreatic carcinoma. Memantine dosage: unknown. During the same period patient was treated with ASPIRIN, AMLODIPINE BESYLATE, VALSARTAN. Patient was hospitalized. Patient died on 04/22/2006.

Memantine Side Effects Report #5147144-7
Memantine side effect was reported by a Health Professional from JAPAN on Oct 27, 2006. Male patient, 78 years of age, weighting 114.6 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: anorexia, dehydration, jaundice cholestatic, malnutrition, metastases to liver, metastases to lymph nodes, pancreatic carcinoma, weight decreased. Memantine dosage: unknown. During the same period patient was treated with ASPIRIN, AMLODIPINE BESYLATE, VALSARTAN, TERBINAFINE, DEXAMETHASONE. Patient was hospitalized. Patient died on 04/22/2006.

Memantine Side Effects Report #5187177-8
Memantine side effect was reported by a Health Professional from JAPAN on Dec 01, 2006. Male patient, 78 years of age, weighting 114.6 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: anorexia, dehydration, jaundice cholestatic, malnutrition, metastases to liver, metastases to lymph nodes, pancreatic neoplasm. Memantine dosage: unknown. During the same period patient was treated with ASPIRIN, AMLODIPINE BESYLATE, VALSARTAN. Patient was hospitalized. Patient died on 04/22/2006.

Memantine Side Effects Report #4994212-6
Memantine side effect was reported by a Health Professional from JAPAN on Apr 26, 2006. Male patient, 78 years of age, weighting 114.6 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: anorexia, bile duct obstruction, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, jaundice cholestatic, malnutrition, metastases to liver, metastases to lymph nodes, pancreatic carcinoma. Memantine dosage: unknown. During the same period patient was treated with ASPIRIN, AMLODIPINE BESYLATE, VALSARTAN, TERBINAFINE, DEXAMETHASONE. Patient was hospitalized. Patient died.

Memantine Side Effects Report #5023103-X
Memantine side effect was reported by a Health Professional from JAPAN on May 26, 2006. Male patient, 78 years of age, weighting 114.6 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: anorexia, bile duct obstruction, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, dehydration, jaundice cholestatic, metastases to liver, metastases to lymph nodes, pancreatic carcinoma metastatic. Memantine dosage: unknown. During the same period patient was treated with ASPIRIN, AMLODIPINE BESYLATE, VALSARTAN, TERBINAFINE, DEXAMETHASONE. Patient was hospitalized. Patient died.


Memantine Side Effects Report #5067213-X
Memantine side effect was reported by a Health Professional from JAPAN on July 20, 2006. Male patient, 68 years of age, weighting 110.2 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: abdominal pain , alanine aminotransferase increased, albumin globulin ratio abnormal, anorexia, aspartate aminotransferase increased, blood calcium decreased, blood chloride decreased, blood glucose increased, blood lactate dehydrogenase increased. Memantine dosage: 20 MG QD PO. During the same period patient was treated with HYDROXYZINE, ZOLPIDEM TARTRATE, METOPROLOL TARTRATE, TRAZODONE. Patient was hospitalized. Patient died on 03/29/2006.

Memantine Side Effects Report #5110836-X
Memantine side effect was reported by a Consumer or non-health professional from JAPAN on Sept 11, 2006. Male patient, 68 years of age, weighting 110.2 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: abdominal pain , alanine aminotransferase increased, albumin globulin ratio decreased, anorexia, aspartate aminotransferase increased, blood calcium decreased, blood chloride decreased, blood cholinesterase decreased, blood creatine phosphokinase increased. Memantine dosage: 20 MG QD PO. During the same period patient was treated with HYDROXYZINE, ZOLPIDEM TARTRATE, METOPROLOL TARTRATE. Patient was hospitalized. Patient died on 03/29/2006.

Memantine Side Effects Report #5748899-0
Memantine side effect was reported by a Consumer or non-health professional from JAPAN on May 09, 2008. Male patient, 68 years of age, weighting 110.2 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: abasia, abdominal pain , alanine aminotransferase increased, albumin globulin ratio decreased, anorexia, aspartate aminotransferase increased, b-cell lymphoma stage iv, blood calcium decreased, blood chloride decreased. Memantine dosage: 20 MG QD;PO. During the same period patient was treated with HYDROXYZINE, ZOLPIDEM TARTRATE, METOPROLOL TARTRATE. Patient was hospitalized. Patient died on 03/29/2006.

Memantine Side Effects Report #4872191-X
Memantine side effect was reported by a Consumer or non-health professional from JAPAN on Dec 26, 2005. Male patient, 68 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: anorexia, cough, difficulty in walking, lymphadenopathy, lymphoma , pyrexia, weight decreased. Memantine dosage: 20 MG QD PO. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #4896757-6
Memantine side effect was reported by a Health Professional from JAPAN on Jan 19, 2006. Male patient, 68 years of age, weighting 110.2 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: anorexia, cough, difficulty in walking, diffuse large b-cell lymphoma stage iv, fall , humerus fracture, pyrexia, weight decreased. Memantine dosage: 20 MG QD PO. Patient was hospitalized. Patient recovered.


Memantine Side Effects Report #4903635-2
Memantine side effect was reported by a Health Professional from GERMANY on Jan 26, 2006. Male patient, 68 years of age, weighting 110.2 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: abasia, anorexia, b-cell lymphoma, cough, fall , humerus fracture, pyrexia, weight decreased. Memantine dosage: 20 MG QD PO. During the same period patient was treated with HYDROXYZINE, ZOLPIDEM TARTRATE, METOPROLOL TARTRATE, TRAZODONE. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #4922747-0
Memantine side effect was reported by a Health Professional from JAPAN on Feb 10, 2006. Male patient, 68 years of age, weighting 110.2 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, b-cell lymphoma stage iv, blood calcium decreased, blood chloride decreased, blood glucose increased, blood lactate dehydrogenase increased, blood potassium decreased. Memantine dosage: 20 MG QD PO. During the same period patient was treated with HYDROXYZINE, ZOLPIDEM TARTRATE, METOPROLOL TARTRATE, TRAZODONE. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #4937122-2
Memantine side effect was reported by a Consumer or non-health professional from JAPAN on Feb 27, 2006. Male patient, 68 years of age, weighting 110.2 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: abasia, alanine aminotransferase increased, albumin globulin ratio decreased, anorexia, aspartate aminotransferase increased, blood calcium decreased, blood cholinesterase decreased, blood glucose increased, blood lactate dehydrogenase decreased. Memantine dosage: 20 MG QD PO. During the same period patient was treated with HYDROXYZINE, ZOLPIDEM TARTRATE, METOPROLOL TARTRATE, TRAZODONE. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #4988330-6
Memantine side effect was reported by a Health Professional from JAPAN on Apr 11, 2006. Male patient, 68 years of age, weighting 110.2 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, albumin globulin ratio decreased, anorexia, aspartate aminotransferase increased, b-cell lymphoma stage iv, blood calcium decreased, blood chloride decreased, blood glucose increased, blood lactate dehydrogenase increased. Memantine dosage: 20 MG QD PO. During the same period patient was treated with HYDROXYZINE, ZOLPIDEM TARTRATE, METOPROLOL TARTRATE, TRAZODONE. Patient was hospitalized. Patient died on 03/29/2006.

Memantine Side Effects Report #5954666-5
Memantine side effect was reported by a Pharmacist from GERMANY on Nov 04, 2008. Male patient, 84 years of age, was treated with Memantine. After drug was administered, patient experienced the following side effects: anorexia, depressed mood, hypotonia, somnolence. Memantine dosage: 5 MG (5 MG, 1 IN 1 D), ORAL. During the same period patient was treated with RAMINYL. Patient recovered.